Brazil
Mabe Bio, founded in 2022, is a promising greentech startup based in São Paulo, pioneering the intersection of technology and nature under the umbrella of biotechnology. Their unique approach involves transforming plants into high-value materials, such as bioplastic and their flagship product, Angico bioleather. This innovative material aims to disrupt traditional leather production methods with its ecosystem-centric processes and advanced green technology.
Committed to sustainability, Mabe Bio offers compelling solutions for industries intent on minimizing their carbon footprint. This positions the company strongly in an era where sustainability is no longer optional but essential. Although they are still in an early stage, opening their Seed Round signifies an ambitious growth trajectory. Based in Brazil, Mabe Bio is set to contribute significantly to sustainable material innovation, a prospect that should be highly appealing to forward-thinking investors.
